Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
- PMID: 35162359
- PMCID: PMC8835454
- DOI: 10.3390/ijerph19031336
Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
Abstract
Polycystic ovary syndrome (PCOS) is increasingly recognized as a complex metabolic disorder that manifests in genetically susceptible women following a range of negative exposures to nutritional and environmental factors related to contemporary lifestyle. The hypothesis that PCOS phenotypes are derived from a mismatch between ancient genetic survival mechanisms and modern lifestyle practices is supported by a diversity of research findings. The proposed evolutionary model of the pathogenesis of PCOS incorporates evidence related to evolutionary theory, genetic studies, in utero developmental epigenetic programming, transgenerational inheritance, metabolic features including insulin resistance, obesity and the apparent paradox of lean phenotypes, reproductive effects and subfertility, the impact of the microbiome and dysbiosis, endocrine-disrupting chemical exposure, and the influence of lifestyle factors such as poor-quality diet and physical inactivity. Based on these premises, the diverse lines of research are synthesized into a composite evolutionary model of the pathogenesis of PCOS. It is hoped that this model will assist clinicians and patients to understand the importance of lifestyle interventions in the prevention and management of PCOS and provide a conceptual framework for future research. It is appreciated that this theory represents a synthesis of the current evidence and that it is expected to evolve and change over time.
Keywords: diet; endocrine-disrupting chemicals; environment; evolution; infertility; insulin resistance; lifestyle; polycystic ovary syndrome; toxins.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Developmental origins and transgenerational inheritance of polycystic ovary syndrome.Aust N Z J Obstet Gynaecol. 2021 Dec;61(6):922-926. doi: 10.1111/ajo.13420. Epub 2021 Aug 17. Aust N Z J Obstet Gynaecol. 2021. PMID: 34403138 Review.
-
Pathophysiological Effects of Contemporary Lifestyle on Evolutionary-Conserved Survival Mechanisms in Polycystic Ovary Syndrome.Life (Basel). 2023 Apr 20;13(4):1056. doi: 10.3390/life13041056. Life (Basel). 2023. PMID: 37109585 Free PMC article. Review.
-
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: an evolutionary metabolic adaptation.Reproduction. 2025 Mar 24;169(4):e250021. doi: 10.1530/REP-25-0021. Print 2025 Apr 1. Reproduction. 2025. PMID: 40080428 Review.
-
Polycystic ovary syndrome and environmental toxins.Fertil Steril. 2016 Sep 15;106(4):948-58. doi: 10.1016/j.fertnstert.2016.08.031. Epub 2016 Aug 22. Fertil Steril. 2016. PMID: 27559705 Review.
-
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.Hum Reprod. 2014 Jul;29(7):1526-35. doi: 10.1093/humrep/deu114. Epub 2014 May 19. Hum Reprod. 2014. PMID: 24842895
Cited by
-
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.Cells. 2022 Dec 31;12(1):174. doi: 10.3390/cells12010174. Cells. 2022. PMID: 36611967 Free PMC article. Review.
-
Editorial: Epigenetics of polycystic ovary syndrome.Front Endocrinol (Lausanne). 2023 Sep 11;14:1284351. doi: 10.3389/fendo.2023.1284351. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37766688 Free PMC article. No abstract available.
-
Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model.J Clin Med. 2025 Jun 6;14(12):4021. doi: 10.3390/jcm14124021. J Clin Med. 2025. PMID: 40565766 Free PMC article. Review.
-
Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome.J Endocr Soc. 2023 Sep 7;7(10):bvad112. doi: 10.1210/jendso/bvad112. eCollection 2023 Aug 28. J Endocr Soc. 2023. PMID: 37693687 Free PMC article. Review.
-
Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.BMC Microbiol. 2024 May 17;24(1):169. doi: 10.1186/s12866-024-03329-x. BMC Microbiol. 2024. PMID: 38760705 Free PMC article.
References
-
- Gakidou E., Afshin A., Abajobir A.A., Abate K.H., Abbafati C., Abbas K.M., Abd-Allah F., Abdulle A.M., Abera S.F., Aboyans V., et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345–1422. doi: 10.1016/S0140-6736(17)32366-8. - DOI - PMC - PubMed
-
- Parker J. NEM: A New Paradigm for Understanding the Common Origins of the Chronic Disease Epidemic. ACNEM J. 2018;37:6–11.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical